http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113582958-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4192 |
| filingDate | 2020-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2023-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2023-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113582958-B |
| titleOfInvention | Flavan derivatives and their preparation and application |
| abstract | The invention belongs to the field of medicinal chemistry and relates to flavan derivatives and their preparation methods and applications, in particular to flavan derivatives and their preparation methods and their application in the preparation of anti-senile dementia medicines. The present invention provides flavan derivatives represented by general formula (I), (II), (III) or (IV), their stereoisomers or pharmaceutically acceptable salts, wherein R 1 ‑R 6 is as claimed in described in the requirements and instructions. The flavan derivatives of the present invention, their stereoisomers or pharmaceutically acceptable salts or their pharmaceutical compositions have obvious Aβ protein, acetylcholinesterase, butyrylcholinesterase inhibitory activity, and can be used to prepare Anti-senile dementia drugs. |
| priorityDate | 2020-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 116.